 |
PDBsum entry 3qfv
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3qfv
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Mrck beta in complex with tpca-1
|
|
Structure:
|
 |
Cdc42bpb protein. Chain: a, b. Fragment: unp residues 1-415. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: cdc42bpb, mrck beta. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.65Å
|
R-factor:
|
0.196
|
R-free:
|
0.268
|
|
|
Authors:
|
 |
T.J.Heikkila,E.Wheatley,D.Crighton,E.Schroder,A.Boakes,S.J.Kaye, M.Mezna,L.Pang,M.Rushbrooke,A.Turnbull,M.F.Olson
|
|
Key ref:
|
 |
T.Heikkila
et al.
(2011).
Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.
Plos One,
6,
e24825.
PubMed id:
|
 |
|
Date:
|
 |
|
23-Jan-11
|
Release date:
|
12-Oct-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9Y5S2
(MRCKB_HUMAN) -
Serine/threonine-protein kinase MRCK beta from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1711 a.a.
395 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Plos One
6:e24825
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.
|
|
T.Heikkila,
E.Wheatley,
D.Crighton,
E.Schroder,
A.Boakes,
S.J.Kaye,
M.Mezna,
L.Pang,
M.Rushbrooke,
A.Turnbull,
M.F.Olson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |